NetworkNewsBreaks – Therma Bright Inc. (TSX.V: T
Post# of 62
Therma Bright (TSX.V: THRM) (OTC: THRBF) targets the $10.7 billion skin-care device market with products that leverage innovative technology to address dermatological needs. A recent article discussing the company reads, “The foundation of Therma Bright’s noninvasive, pain-free skin care offerings is proprietary technology that has received class II medical device status from the U.S. Food and Drug Administration (‘FDA’). The company’s products include the InteceptCS Cold Sore Prevention Device and the TherOZap Insect Bite Treatment Device. One focus of Therma Bright’s products, devices and treatments is providing relief of pain, itch and inflammation resulting from over 20,000 kinds of insect and marine life bites and stings.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer